Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells

U Testa, E Pelosi, G Castelli - Medical Sciences, 2018 - mdpi.com
Colon cancer is the third most common cancer worldwide. Most colorectal cancer
occurrences are sporadic, not related to genetic predisposition or family history; however, 20 …

The roles of ROS in cancer heterogeneity and therapy

PL de Sá Junior, DAD Câmara… - Oxidative medicine …, 2017 - Wiley Online Library
Cancer comprises a group of heterogeneous diseases encompassing high rates of
morbidity and mortality. Heterogeneity, which is a hallmark of cancer, is one of the main …

Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA–MUF interaction with ANXA2 and miR-34a

X Yan, D Zhang, W Wu, S Wu, J Qian, Y Hao, F Yan… - Cancer research, 2017 - AACR
Accumulating evidence suggests that cancer-associated mesenchymal stem cells (MSC)
contribute to the development and metastasis of hepatocellular carcinoma (HCC). Aberrant …

Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis

H Yuan, N Li, D Fu, J Ren, J Hui, J Peng… - The Journal of …, 2017 - Am Soc Clin Investig
The histone H3K36 methyltransferase SETD2 is frequently mutated or deleted in a variety of
human tumors. Nevertheless, the role of SETD2 loss in oncogenesis remains largely …

RNAPII-dependent ATM signaling at collisions with replication forks

E Einig, C Jin, V Andrioletti, B Macek… - Nature …, 2023 - nature.com
Abstract Deregulation of RNA Polymerase II (RNAPII) by oncogenic signaling leads to
collisions of RNAPII with DNA synthesis machinery (transcription-replication conflicts …

Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?

C Disoma, Y Zhou, S Li, J Peng, Z Xia - Biochimie, 2022 - Elsevier
The Wnt/β-catenin signaling pathway has been implicated as the central mechanism that
drives colorectal carcinogenesis. Its activation is historically due to mutation on APC …

Targeting the β-catenin signaling for cancer therapy

X Zhang, L Wang, Y Qu - Pharmacological research, 2020 - Elsevier
Abstract β-catenin is the key transducer of the canonical Wnt signaling. Aberrant activation of
β-catenin has been tightly connected to the initiation and progression of various cancers …

NEDD4 and NEDD4L regulate Wnt signalling and intestinal stem cell priming by degrading LGR5 receptor

L Novellasdemunt, A Kucharska, C Jamieson… - The EMBO …, 2020 - embopress.org
The intestinal stem cell (ISC) marker LGR5 is a receptor for R‐spondin (RSPO) that functions
to potentiate Wnt signalling in the proliferating crypt. It has been recently shown that Wnt …

β-catenin inhibitors in cancer therapeutics: intricacies and way forward

A Dev Jr, M Vachher, CP Prasad - Bioengineered, 2023 - Taylor & Francis
ABSTRACT β-catenin is an evolutionary conserved, quintessential, multifaceted protein that
plays vital roles in cellular homeostasis, embryonic development, organogenesis, stem cell …

WNT4 secreted by tumor tissues promotes tumor progression in colorectal cancer by activation of the Wnt/β-catenin signalling pathway

D Yang, Q Li, R Shang, L Yao, L Wu, M Zhang… - Journal of Experimental …, 2020 - Springer
Abstract Background Wingless and Int-related protein (Wnt) ligands are aberrantly
expressed in patients with colorectal cancer (CRC). However, the aberrant level of Wnt …